- US12584144utility2026Universal Donor Cells0 cites
- US12577582utility2026Universal Donor Cells0 cites
- US12559726utility2026Universal Donor Cells0 cites
- US12553030utility2026Genetically Engineered T Cells with PTPN2 Knockout Have Improved Functionality and Anti-tumor Activity0 cites
- US12427170utility2025Universal Donor Cells0 cites
- US12378572utility2025Universal Donor Cells0 cites
- US12365915utility2025Universal Donor Cells0 cites
- US12344655utility2025Gene-edited Natural Killer Cells0 cites
- US12344656utility2025Genetically Engineered T Cells Having Improved Persistence in Culture0 cites
- US12304968utility2025T-cells Expressing Anti-liv1 Chimeric Antigen Receptor0 cites
- US12241087utility2025Compositions and Methods for Differentiating Stem Cells Into NK Cells0 cites
- US12227763utility2025Methods and Compositions for Treating Cancer0 cites
- US12186406utility2025Materials and Methods for Treatment of Hereditary Haemochromatosis0 cites
- US12188060utility2025Messenger RNA Encoding Cas9 for Use in Genome-editing Systems0 cites
- US12037616utility2024Methods and Compositions for Treating Angiopoietin-like 3 (ANGPTL3) Related Conditions0 cites
- US11958908utility2024Compositions and Methods for the Depletion of CD117+ Cells0 cites
- US11920148utility2024Compositions and Methods for Gene Editing0 cites
- US11866727utility2024Materials and Methods for Treatment of Glycogen Storage Disease Type 1A0 cites
Page 1 of 2Next →